Optimi Health Corp. (8BN.F)
- Previous Close
0.2080 - Open
0.2300 - Bid 0.2200 x --
- Ask 0.2420 x --
- Day's Range
0.2300 - 0.2300 - 52 Week Range
0.0930 - 0.2820 - Volume
200 - Avg. Volume
205 - Market Cap (intraday)
20.669M - Beta (5Y Monthly) 1.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Optimi Health Corp. engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of fungi varieties, including Lion's Mane, Chaga, Reishi, Turkey Tail, and Cordyceps. It sells its products through www.optimilife.com, an e-commerce website platform; and Amazon marketplace, and distributors/brokers. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is based in Garibaldi Highlands, Canada.
www.optimihealth.ca--
Full Time Employees
September 30
Fiscal Year Ends
Sector
Recent News: 8BN.F
Performance Overview: 8BN.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8BN.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8BN.F
Valuation Measures
Market Cap
20.67M
Enterprise Value
22.13M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
124.51
Price/Book (mrq)
2.48
Enterprise Value/Revenue
92.74
Enterprise Value/EBITDA
-5.04
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-19.35%
Return on Equity (ttm)
-36.35%
Revenue (ttm)
238.62k
Net Income Avi to Common (ttm)
-5.24M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
493.18k
Total Debt/Equity (mrq)
21.77%
Levered Free Cash Flow (ttm)
-3.45M
Company Insights: 8BN.F
8BN.F does not have Company Insights